Virally induced liver cancer usually evolves over long periods of time in the context of a
strongly oxidative microenvironment, characterized by chronic liver inflammation and …

Hepatoprotective effects of natural compounds have been frequently attributed to their
antioxidant properties and the ability to mobilize endogenous antioxidant defense system …

Hepatitis B virus (HBV) infection is a major health problem worldwide, and chronically
infected individuals are at high risk of developing cirrhosis and hepatocellular carcinoma …

With respect to their genome and their structure, the human hepatitis B virus (HBV) and
hepatitis C virus (HCV) are complete different viruses. However, both viruses can cause an …

Hepatitis B virus X protein (HBx) contributes to Hepatitis B virus (HBV)-related liver cancer.
However, its impact on hepatocyte proliferation and genomic stability remains elusive. We …

Chronic hepatitis B virus (HBV) infections and colorectal cancer (CRC) are prevalent in
Taiwan. We carried out a population-based case-control study to assess the association …

Background Hepatocellular carcinoma (HCC) has become the main cause of cancer death
worldwide. More than half of hepatocellular carcinoma developed from hepatitis B virus …

Chronic hepatitis B virus infection (CHB) caused by the hepatitis B virus (HBV) is one of the
most common viral infections in the world. Reactivation of HBV infection is a life-threatening …

Proteasomal activator 28 gamma (PA28γ) upregulates the levels of HBx, a regulatory protein
of hepatitis B virus (HBV) to stimulate HBV replication; however, the detailed mechanism …

Proteasomal activator gamma (PA28γ), frequently overexpressed in hepatocellular
carcinoma, is believed to play important roles in tumourigenesis. However, the underlying …